Robarts Clinical Trials   Report issue

For profit Phase 2 Phase 3
Founded: London Canada (1986)

Organization Overview

First Clinical Trial
2005
NCT00132899
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alimentiv Inc. | Robarts Clinical Trials, Robarts Research Institute | Robarts Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 2)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 3)

Metabolic Syndrome (Phase 2)

Syndrome (Phase 2)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8